

Hormone Therapy Guide · Vyta MenoClinic
Hormone replacement therapy has been misunderstood, misrepresented, and withheld from millions of women who could benefit. This guide gives you the real evidence — so you can make an informed decision with your physician.

The History
In 2002, the Women's Health Initiative (WHI) published a study claiming HRT increased breast cancer risk. Overnight, prescriptions plummeted — and millions of women were left to suffer without treatment.
The study had serious flaws: it used synthetic progestins (not bioidentical progesterone), enrolled women who were significantly older and sicker than typical HRT candidates, and misrepresented statistical risk.
The science has since been substantially revised. Every major menopause society — including The Menopause Society (NAMS) — now states that HRT is safe and effective for most healthy women under 60.
What We Know Now
Myth vs. Reality
Myth
HRT causes breast cancer
Evidence
The risk was vastly overstated by a 2002 WHI study now known to have significant methodological flaws. Most women starting HRT at menopause do not have increased breast cancer risk — and many have reduced risk when started in the "window of opportunity."
Myth
HRT should only be used short-term
Evidence
There is no medical mandate for a time limit on HRT. The "5-year rule" was an artifact of outdated guidelines. Current evidence supports continued use as long as benefits outweigh risks — which for most healthy women, they do.
Myth
All hormones are the same
Evidence
Synthetic progestins (used in older HRT formulas) are not equivalent to bioidentical progesterone. The type, route, dose, and timing of hormones matter enormously — which is why Vyta individualizes every protocol.
Myth
If your symptoms aren't severe, you don't need HRT
Evidence
Hormone therapy has benefits beyond symptom relief: bone protection, cardiovascular benefit when started early, cognitive protection, and long-term metabolic health. You don't need to be suffering to benefit.
Myth
You can't start HRT after 60
Evidence
While the "timing hypothesis" suggests early start is optimal, HRT can be considered at any age with proper physician evaluation. The risk-benefit equation changes with age — but it doesn't automatically tip against HRT.
For women without a uterus
Delivery Routes
Best for: Post-hysterectomy women or those needing flexible dosing options.
For women with a uterus
Delivery Routes
Best for: Women with an intact uterus — progesterone protects the uterine lining.
Molecularly identical to human hormones
Delivery Routes
Best for: Women who want hormones that match their body's own molecular structure.
Often overlooked in women
Delivery Routes
Best for: Women with low libido, energy issues, muscle loss, or mood symptoms alongside estrogen therapy.
Minimal systemic absorption
Delivery Routes
Best for: Women with GSM symptoms only, or those who prefer to avoid systemic hormones.
Week 1–2
Sleep often improves first. Some women notice mood stabilization within days of progesterone.
Week 2–4
Vasomotor symptoms typically begin reducing. Night sweats decrease in frequency and severity.
Month 1–2
Most women notice sustained energy improvements, reduced brain fog, and emotional stability.
Month 2–3
Sexual health improvements and skin texture changes become noticeable, especially with testosterone.
Month 3–6
Labs are re-drawn. Doses are refined. Long-term bone, cardiovascular, and cognitive benefits begin accruing.

A Vyta physician will review your full hormone history, run a comprehensive panel, and help you decide whether — and what type of — hormone therapy is right for you.
Book a Hormone Consultation